top of page
_tif.png)
News
2021/03/18
Regarding the SARS-CoV-2 antibody system that jointly developed by OMR, Euglena and Leave a Nest, Euglena has launched a service for medical institutions
Regarding the SARS-CoV-2 antibody system that jointly developed by Order-made Medical Research Inc.(President: Yasufumi Murakami), Euglena Co., Ltd. (President: Mitsuru Izumo) and Leave a Nest Co., Ltd. (CTO: Joe Inoue), Euglena has launched a service for medical institutions.
For details, please see the press release from Euglena Co., Ltd.
bottom of page